Ticker: PTGX

**Protagonist Therapeutics, Inc.** (NASDAQ: PTGX) has released its quarterly results for the period ending March 31, 2025, highlighting both growth opportunities and challenges faced by the company. Below are key points extracted from their income statement and overall financial position: Positiv...